Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to serve patient needs and strives to provide future generations with a world where quality healthcare is available and accessible to all. See our community guidelines here: https://www.servier.us/community-guidelines To report a suspected adverse event with a Servier product, please visit: https://www.servier.us/contact-us

Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the area of bone health. Our team works collaboratively and relentlessly to advance our therapies with the goal of improving the lives of patients, their families, and their caregivers. Radius was founded in 2003 and has locations in Boston, Massachusetts, and Wayne, Pennsylvania. If you think you have the same passion and commitment we have, check out www.radiuspharm.com.

Twin Rivers Technologies is one of the largest Oleochemical producers in North America. We provide solutions that deliver superior quality, service, and value to our customers. The relationships we have developed with our customers and within our communities are based on open communications, trust, and delivering only one standard of performance -- "the best in all that we do."​ Twin Rivers Technologies is focused on satisfying our customers and growing our business. Our foundation is firmly established in creating a safe, clean and compliant atmosphere for our employees and communities. We have developed core competencies in designing and implementing flexible business structures and organizations. Technological know-how and supply chain expertise are our core competencies. Visit our blog at http://blog.twinriverstechnologies.com/blog

Specializing in recombinant and traditional chromogenic and turbidimetric reagent technologies, ACC has been a global leader in endotoxin and (1→3)-ß-D-glucans detection products and services for 50 years. ACC pioneered LAL testing methodology and was the first FDA licensed company to manufacture LAL reagents; ACC has grown to be an internationally recognized leader in endotoxin detection. We are headquartered in Falmouth, MA with facilities in the UK and the Netherlands. With a dedication to quality, ACC is certified to I.S. EN ISO 13485:2016 and ISO 13485:2016. We are FDA inspected and operate DEA Licensed and CLIA-certified laboratories. Our endotoxin detection reagents, instruments and software are used within the Pharmaceutical, Medical-Device, Biotechnology, Compounding Pharmacy and Dialysis industries for quality control, product release and research. ACC operates a Contract Test Services (CTS) Laboratory which has specialized in testing for endotoxin contamination for over 40 years. Our CTS laboratory is GMP compliant, ISO registered and DEA licensed and is capable of handling all controlled drug substances except those included in Schedule 1. All testing services can be performed to FDA, USP, EP and/or JP regulatory guidelines. In addition to routine testing, our CTS Laboratory will customize endotoxin testing, troubleshoot difficult samples, develop and/or transfer LAL test methods, design and produce custom depyrogenation controls for oven validation and perform Low Endotoxin Recovery (LER) studies/protocols. ACC also offers a clinical diagnostics product line and operates a CLIA-certified laboratory specializing in (1→3)-ß-D-glucan analysis to support the early diagnosis of Invasive Fungal Infection (IFI). For more information please visit https://www.linkedin.com/in/fungitell-assay-3269a2154/

Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers. Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.

Founded in 2013, WMG is a leading owner’s representation and construction management firm that specializes in aviation and large commercial projects. Our team is known for its delivery of end-to-end planning and management services, including permit management, owner’s rep services, quality control and environmental management. Our team of professionals remain focused on delivering the company’s core services, which has created a reputation of exceptional client experience and deep expertise. Headquartered in El Segundo, California, WMG serves clients across the country and has a long history leading projects in California, Washington and Nevada.

JET Tech is a volunteer network of local Information Technology (IT) professionals providing services to help people navigate the IT profession. We are experienced professionals who offer guidance to those considering entering the field, those with any amount of experience, and those looking to transition their careers. We network with peers and share information about job openings to assist candidates with job placement. JET Tech is also a source of education for the community offering presentations and lectures on industry trends and developments as well as practical introductions to different facets of IT.

Superior chemistry. Expertly applied. Alpha Chemical Services is an industry leader in the formulation and manufacturing of specialty cleaning and sanitation solutions. For over 50 years, our expertise, chemistry, and personalized services have provided total confidence to our customers in the food & beverage, foodservice, industrial, institutional and retail markets. Alpha delivers comprehensive chemical blending and packaging solutions with full private label services. Our manufacturing facilities are ISO 9001:2015 certified and are registered chemical blending facilities for: EPA, NSF, Kosher, Green Seal, and Safer Choice. Private label packaging, and toll manufacturing services are available for products in liquid, powder, solid and portion control packaging. Our quality control standards and procedures meet the strictest customer specifications.

Who We Are: Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team. What We Do: We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy and depression. Our flagship azetukalner program represents the most advanced potassium channel modulator in clinical development for multiple indications. Building upon the positive results and compelling data from our Phase 2b “X-TOLE” study in adult patients with focal epilepsy, our Phase 3 epilepsy program includes multiple clinical trials evaluating azetukalner in patients with focal onset seizures and primary generalized tonic-clonic seizures. In 2024, we are planning to initiate a Phase 3 azetukalner program in major depressive disorder, based on topline data from our Phase 2 “X-NOVA” clinical trial. In addition, we are proud of the leading-edge science coming out of our discovery labs, including early-stage research programs that leverage our extensive ion channel expertise and drug discovery capabilities to identify validated drug targets and develop new product candidates. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.

Hauthaway Corporation is an innovative designer of polyurethane polymers and compounded finishing materials for applications that require the very best. With our strong research capability and experienced applications support, we continually endeavor to meet the challenges faced by formulators and end-users in a variety of industries, including automotive, biomedical, construction, maintenance, and textile. Hauthaway’s broad water-based polyurethane dispersion portfolio affords formulators options for compounding coatings for wood and concrete flooring, automotive interior plastics, leather seating and garments, and flame retardant finishes for textiles. Headquartered in Lynn, Massachusetts, the company has an international distribution organization covering North America, Europe and Asia-Pacific regions. With a 155 year history of growth and innovation, the focus of our management team is on continuing to serve our diverse customer base and on translating successes to new markets such as architectural coatings, and adhesives. In addition to our unique product offerings, Hauthaway operates under an ISO 9001:2000 recognized management system with strict manufacturing and quality control guidelines.

Since 2003, Environmental Operating Solutions, Inc. (EOSi) has been committed to “Empowering Clean Water” and has led the industry in helping its customers to comply with increasingly stringent discharge regulations for nitrogen, phosphorous, selenium and perchlorate contamination. EOSi builds long-term partnerships with its customers by providing complete treatment solutions that typically include its proprietary, environmentally sustainable MicroC® supplemental carbon products, process monitoring and control systems, and highly qualified process engineers, who provide on-going technical support. EOSi’s goal is to ensure its customers maintain environmental permit compliance at the lowest possible cost. As a result, EOSi’s team of 30+ employees have become the #1 provider of supplemental carbon programs to the U.S. water treatment industry, serving more than 600 customer sites from a network of 20 manufacturing sites across the U.S. EOSi is based in Pocasset, Massachusetts. EOSi is part of a nutrient removal platform called Axius Water, formed by KKR and XPV Water Partners. KKR is a leading global investment firm and the platform is part of the Firm’s Global Impact strategy. XPV Water Partners is the leading private equity firm focused exclusively on making a difference in water.

Ensoma /en’sōmə/ is derived from the Greek phrase “en soma,” meaning in the body. We develop one-time in vivo treatments that precisely engineer any or all blood and immune cells to cure diseases from within. We have a bigger, bolder vision for genomic medicine: treatments as versatile, precise, and far-reaching as the body’s own cells. Our team takes inspired action towards pushing beyond today’s possible with the goal of delivering a one-time, off-the-shelf treatment to patients everywhere.